ZNF137P

Across TCGA pan-cancer cohorts, ZNF137P mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated ZNF137P data layer compared with 22 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher ZNF137P mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated ZNF137P expression acts as an unfavorable survival marker, although some lineages such as LUAD and LSCC show a favorable association.

LUAD, PDAC, and LSCC are the cancer types where ZNF137P mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	All	0.896	0.440	.017	8	view →
PDAC	DFS	Median	III,IV	0.122	0.984	.038	3	view →
LSCC	DFS	Quartile	All	0.938	0.480	.017	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

ZNF137P–LUAD (DFS)

Open the LUAD breakdown →